Cytiva and Rockwell Automation Launch Figurate SCADA Platform to Streamline Digital Biopharma Manufacturing

Cytiva, a Danaher company and a leader in the life sciences industry, and Rockwell Automation,  Inc. (NYSE: ROK), the world’s larg...

May 04, 2026 | Monday | News
Redefining Precision Fluid Management in Cardiorenal Care

Fluid overload remains one of the most complex and costly challenges in cardiorenal care, particularly for patients who no longer respond to conventional d...

May 04, 2026 | Monday | Interview
Turning Clinical Complexity into Predictive Intelligence: How BullFrog AI Is Redefining Drug Development

As pharmaceutical companies continue to face high attrition rates, rising development costs and increasingly complex clinical datasets, the industry is sea...

May 04, 2026 | Monday | Interview
Cleaning Beyond Compliance: How Biopharma Manufacturers Can Unlock Capacity Through Smarter Contamination Control

  As biologics manufacturing operations become increasingly complex, biopharma companies are under growing pressure to improve efficiency, strengthen...

May 04, 2026 | Monday | Interaction
Circular Genomics and Vitazi.ai Partner to Advance Multimodal Early Detection of Alzheimer’s Disease

Analytical Framework Combines AI-Powered Retinal Imaging with Proprietary Circular RNA Biomarkers to Unlock Scalable, Non-Invasive Pathway for Early-Stag...

May 01, 2026 | Friday | News
Anixa Biosciences Secures Mexico Patent for Breast Cancer Vaccine, Extending IP Protection to 2040

Expands global intellectual property coverage in markets with greater late-stage breast cancerdiagnoses and higher triple-negative breast cancer incidenc...

May 01, 2026 | Friday | News
TrialClinIQ Secures Pre-Seed Funding and Accelerator Backing to Advance Equitable Clinical Trial Access

TrialClinIQ, an AI-powered clinical trial recruitment platform based in Houston, Texas advancing health equity, announced a $150K pre-seed investment fro...

April 30, 2026 | Thursday | News
Mesoblast Limited Advances Phase 3 Program for Rexlemestrocel-L with Full Enrollment in Chronic Low Back Pain Trial

Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, announced that its pivotal Phase 3 cl...

April 30, 2026 | Thursday | News
Thermo Fisher Scientific to Divest Microbiology Unit to Astorg in $1.075 Billion Deal

Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that it has signed a definitive agreement to sell its microbiol...

April 29, 2026 | Wednesday | News
PCI Pharma Services Commits Over $1 Billion to Expand Sterile Fill-Finish and Drug-Device Capabilities Across US and Europe

PCI Pharma Services (“PCI”) – a world-leading integrated global contract development and manufacturing organization (CDMO) focused on i...

April 29, 2026 | Wednesday | News
AIDS Healthcare Foundation Presses Shareholders to Challenge Gilead Sciences Patent Strategy at 2026 AGM with Proposal 6

With Proposal #6, AIDS group urges shareholders to vote to request the company produce a report on the impact of extended patent exclusivities on patie...

April 29, 2026 | Wednesday | News
CREATE Medicines Doses First Patient in Phase 1/2 Trial of MT-304, Advancing In Vivo Multi-Immune CAR Therapy

Validates platform's ability to rapidly iterate across immune cell types Leverages novel NK and myeloid co-programming architecture to deliver coordin...

April 28, 2026 | Tuesday | News
Dark Horse Consulting Group and Porton Advanced Forge Strategic Alliance to Accelerate Global Cell and Gene Therapy Development

Dark Horse Consulting Group (“DHCG” or “the Group”), a leader in strategic and operational biotherapeutics consulting, and Porton...

April 28, 2026 | Tuesday | News
OSE Immunotherapeutics Welcomes FDA Orphan Drug Designation for Pegrizeprument (VEL-101) in Heart Transplant Rejection Prevention

OSE Immunotherapeutics SA  welcomes the announcement by its partner Veloxis Pharmaceuticals, Inc. that the U.S. Food and Drug Administration (FDA) h...

April 28, 2026 | Tuesday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2026 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close